Status:
COMPLETED
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Conditions:
Fuchs' Endothelial Dystrophy
Eligibility:
All Genders
40+ years
Phase:
EARLY_PHASE1
Brief Summary
This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative c...
Detailed Description
Subjects meeting inclusion criteria will be identified by Massachusetts Eye and Ear cornea surgeons during their pre-operative assessment and invited to participate in the study. Written informed cons...
Eligibility Criteria
Inclusion
- Fuchs corneal dystrophy
Exclusion
- Women of childbearing potential
- Other corneal eye diseases
- Non-compliance with netarsudil
- Intolerance of netarsudil
Key Trial Info
Start Date :
March 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04752020
Start Date
March 28 2021
End Date
December 30 2023
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States, 02127